title : Lecturer
College : Al-Zahra Medical College
Department : General
Email : mazin.hazza@uobasrah.edu.iq
Title of the activity | Activity type | Year | local |
---|---|---|---|
Abbot innovations in cardiac rhythm mangement | Training course | 2024 | |
Heart Failure recommendations and diagnosis challenges | Training course - Lecturer | 2024 | |
CRM interconnection in T2D and the role of Glyxambi® in optimizing metabolic parameter control | Conference - Participant | 2024 | |
Bridging the energy gap between hemodynamic and metabolic in angina management | Conference - Participant | 2024 | |
Basics of ECG | Training course - Lecturer | 2024 | |
heart failure recommendations and diagnosis challenges | Conference - Keynote Speaker | 2024 | |
nebivolol a 3rd generation beta. blocker | Conference - Keynote Speaker | 2024 | |
dyslipdemia : from definitions to the practice | Training course - Lecturer | 2024 | |
important initiative in LDL cholesterol mangement, a call to action | Lecture | 2024 | |
Clinical Excellence in Hypertension Management: Aligning with Guidelines for Better Outcomes | Conference - Participant | 2024 | |
Sacubitril/Valsartan: clinical benefits across the Spectrum of Ejection Fraction in Heart Failure | Training course - Lecturer | 2024 | |
Fabery disease | Training course - Lecturer | 2024 | |
The role of SGL2 inhibitors in heart failure | Lecture | 2023 | |
EmpagliflozinA unique movement in diabetes | Training course - Lecturer | 2023 | |
RV dysplasia | Conference - Keynote Speaker | 2023 | |
early heart failure and renal risks(incidence and impactonQOL) | Lecture | 2023 | |
Dyslipdemia mangement: should be go lower and faster? | Lecture | 2023 | |
beta blockers,ZOK, in heart failure | Lecture | 2023 | |
empagliflzine and heart failure | Lecture | 2022 | |
role of ticagrelor in primary PCI in Basra | Lecture | 2021 | |
new angiotensin blocker ,Azelsartan | Lecture | 2021 | |
speckle traking echocardiography | Lecture | 2021 | |
BEST OF AHA 2020-IRAQ | Lecture | 2021 | ![]() |